43 results
6-K
EX-10.1
BLRX
BioLineRx Ltd.
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery
20-F/A
2023 FY
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
cybersecurity threats, or provide assurances that we have not experienced an undetected cybersecurity incident. For more information about these risks
20-F/A
2023 FY
EX-2.1
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
of the Israeli Securities Law, including reasonable legal expenses, which term includes attorney fees; and
any other incident for which
6-K
EX-99
BLRX
BioLineRx Ltd.
30 Aug 23
Current report (foreign)
6:45am
and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation
6-K
EX-10.1
pl4zc3
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
d4607q7 169h
3 Sep 21
Current report (foreign)
4:30pm
POS AM
ncj03u
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
1vkl0hg2otq 48
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-10.1
bsvlwwl8kcbs7br tuq
25 Sep 20
Current report (foreign)
4:33pm
POS AM
a00d41 q3u
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
424B3
q1mm1nyi7v6 imi
2 Jul 20
Prospectus supplement
4:28pm
F-1
9jyg8l86f9clmeoh2
26 Jun 20
Registration statement (foreign)
4:30pm
6-K
EX-99
lbrfs
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
u3h2t1x2dx4
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
9ta8r4hmd vqt86
7 Feb 19
As Representative of the several Underwriters
12:00pm
20-F/A
EX-4.39
svxwsvgn irl
22 Sep 15
Annual report (foreign) (amended)
12:00am